Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiotherapy
Pharma
Eli Lilly hit with Verzenio flop in prostate cancer
Despite reaching new heights in breast cancer, Eli Lilly’s Verzenio has been sent packing in prostate cancer.
Angus Liu
Feb 7, 2024 10:44am
Novartis eyes $1B Lutathera acceleration with first-line win
Jan 19, 2024 10:00am
Novartis' largest Pluvicto plant approved by FDA
Jan 5, 2024 11:36am
WuXi, Daiichi-Novartis, Merck KGaA-Abbisko—Fierce Pharma Asia
Dec 8, 2023 8:13am
Novartis commits $85M to build radiotherapy plant in China
Dec 1, 2023 11:06am
ESMO: Novartis' Pluvicto posts mixed prostate cancer data
Oct 23, 2023 10:30am